Delivery Order SPE2DB22D1002-SPE2DB23FLGT8

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $3,982 to Amerisourcebergen Drug Corporation to supply 120ml of Quillivant XR 25mg/5ml suspension. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product to a location in Conshohocken, Pennsylvania under a one-day period of performance beginning August 2nd and concluding on August 3rd, 2023. The Defense Logistics Agency functions to support...

The Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the delivery of 120mL of Quillivant XR 25 mg/5 mL oral suspension. With a potential value of $1,893, this firm fixed price order has an anticipated completion date of October 25, 2023 and was awarded on October 24, 2023. Performance will occur in Conshohocken, Pennsylvania. No set aside designation was applied to...

The Defense Logistics Agency awarded a $2,256.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities. The contract carries an ultimate completion date of September 24, 2025, and represents performance from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and serves as a child contract under...

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,524 to Amerisourcebergen Drug Corporation to supply 120mL of Quillivant XR 25 mg/5 mL oral suspension. The contract has a period of performance from August 22, 2023 through August 23, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were...

The Defense Logistics Agency issued a $1,145.16 delivery order to Amerisourcebergen Drug Corp on May 8, 2026, for Quillivant XR 25 mg/5 ml suspension (60 ml) with an ultimate completion date of May 11, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. This is a transactional pharmaceutical delivery order under the Defense Logistics Agency's standing indefinite delivery contract structure supporting military healthcare supply across federal...

<p>The Defense Logistics Agency issued a $1,514.70 delivery order to Amerisourcebergen Drug Corp on May 5, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of May 6, 2026. This delivery order was issued under a parent indefinite delivery contract with the Defense Logistics Agency supporting pharmaceutical supply to military healthcare systems.</p>

The Defense Logistics Agency awarded a $1,094.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561422654, described as Quillivant XR 25 MG/5 ML Suspension 180ML. The single order is for product delivery to a location in Conshohocken, Pennsylvania, with performance required between July 6-7, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order supports DOD medical supply needs. No...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a contract ceiling value of $2,401.91. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, executed without a set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...

The Defense Logistics Agency awarded a $1,218.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml quantities, with performance completion scheduled for November 4, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a ceiling value of $2,110.28. This is a firm fixed price delivery order under a non-set-aside competitive award. The order is scheduled for completion by September 3, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this...